SimBioSys

We are thrilled to announce our first FDA 510(k) clearance for our digital precision medicine technology, TumorSight™! This milestone allows us to deliver on our vision to redefine precision medicine and revolutionize patient care.

Read more here: businesswire.com/news/home/2024…

We are excited to announce a strategic collaboration with the @MayoClinic for the development of novel digital medicine solutions for patients to help improve quality of life, starting with #breastcancer.

Read more about this exciting collaboration here: businesswire.com/news/home/2024…

It’s not too late to register for @DDWJournal's Cancer Summit! Join our CTO and Co-founder, Dr. Joseph Peterson, alongside other leaders in the field to discuss the latest advancements in cancer drug discovery research.

Register here: register.gotowebinar.com/register/24536…

Interested in learning more about the latest advancements and tools in cancer drug discovery? Our CTO and Co-founder Dr. Joseph Peterson will be speaking alongside other leaders in the field during @DDWJournal's Cancer Summit!

Register: register.gotowebinar.com/register/24536…

As our product pipeline continues to advance, now is the perfect time to update our website to reflect all of our important progress! Learn more about the exciting things happening, including the latest on our TumorSight and PhenoScope platforms: simbiosys.com